This website requires Adobe Flash Player.
Please download the latest Flash Plugin.

You are here

Vitamin C

-A +A
  • Overview
  • Product Profile
 

Diffucaps® Vitamin C (sustained-release)

Nutrition

Sustained-release capsules conveniently provide a 12-hour dose of vitamin C. Vitamin C ranks #2 worldwide in total multi-vitamin supplement sales, and is the leading ‘single’ vitamin supplement in the world.

Vitamin C is water soluble and cannot be stored by the body. Because it is absorbed and excreted rapidly in the gastrointestinal tract, taking an immediate release (IR) supplement does not maintain plasma levels throughout the day.

Our Diffucaps® sustained-release Vitamin C is clinically shown to maintain plasma levels throughout the day. The formulation is more convenient than IR formulations because Diffucaps® Vitamin C provides a continuous release of Vitamin C in smaller doses over a longer period of time, maintaining the nutrient’s levels over an extended period of 12 hours.

Aptalis Pharmaceutical Technologies uses their proprietary Diffucaps® technology to create a sustained-release formulation of this widely used dietary supplement. It can be licensed for use as a pharmaceutical or food product, depending on country.

Diffucaps® Vitamin C (sustained-release)

Nutrition

Therapeutic Category

Nutrition

Indication

Dietary supplement used to:

  • Help maintain the immune system
  • Boost iron absorption
  • Ensure healthy teeth, skin, and gums
  • Aid in wound healing
  • Help the body counteract the negative effects of free radicals
  • Counteract the effects of a poor diet, smoking, stress, illness, aging, and vitamin C deficiency

Development Status

Commercialized; Licensing opportunities available

Available Dosage Strength(s)

  • 500 mg (sustained-release)
  • 60 mg - 500 mg (for use as food product)

Product Description

12-hour sustained-release capsule formulation of vitamin C

Technology

Diffucaps® - Customized Drug Release technology

Licensing Opportunities

Aptalis Pharmaceutical Technologies is seeking licensing partners for global opportunities.

This information is provided solely for the purpose of the evaluation of business opportunities by potential collaboration partners. The information is based on currently existing data and marketing authorizations in a number of jurisdictions and should not be assumed to be approved by regulatory authorities in any individual country. Consumers should consult with their individual physician for product information and should not rely upon any information provided here.

For more information on this product, please contact Aptalis Pharmaceutical Technologies.